|
The Mallinckrodt MGH General Clinical Research Center (GCRC) is a research center at Massachusetts General Hospital. It is located in Boston, Massachusetts, with satellites in Cambridge, MA and Charlestown, MA. It is supported by a GCRC grant through the National Institutes of Health. ==History== The MGH GCRC began as Ward IV in 1925. It was the second clinical research center in the United States. The impetus for its founding came from Joseph Charles Aub, who was supported by James Howard Means and David Linn Edsall, Dean of Medicine at Harvard Medical School. The ward began as just two inpatient beds, accommodating mostly metabolic and endocrine research. Many doctors conducted research on the ward, including endocrinologist Fuller Albright. In the 1940s, Edward Mallinckrodt, Jr., head of the Mallinckrodt Chemical Company and a college friend of Albright's, contributed enough money to fund three additional inpatient beds on the unit. He also started an endowment fund to ensure the continuous operation of Ward IV. As a result of this fund, Ward IV was renovated to put two bed in each of the five inpatient rooms, leading to a total of ten beds. A laboratory, metabolic kitchen, and patient recreation space were also added. In 1949, Ward IV was renamed "Mallinckrodt Ward IV" in honor of Mallinckrodt's contributions. By the 1950s, Ward IV researchers had made many significant contributions. In 1957, Means published a book detailing the ward's history, entitled "Ward 4". In 1978, Ward IV became a GCRC supported by the NIH. In the 1980s, the MGH GCRC moved from its previous location on the first floor of the Bulfinch building to its current location on the thirteenth floor of the White building. Facilities include both inpatient and outpatient rooms, expanded space for staff, a core laboratory, a metabolic kitchen, and an outdoor deck for both patients and staff. The 2000s were a time of great change for the MGH GCRC. The space in the White building was renovated. The MGH GCRC acquired two new satellites, the Clinical Research Center at the Massachusetts Institute of Technology and the Biomedical Imaging Core at the Charlestown Navy Yard. The MGH GCRC was one of the first GCRCs in the nation to have an imaging facility, and remains one of the only few with this technology. The decade will bring more changes for the MGH GCRC, as the NIH recently announced it will be eliminating the GCRC grant in favor of a Clinical and Translational Science Award, or CTSA. The new grant will bring together the GCRCs from MGH, Brigham and Women's Hospital, Beth Israel Deaconess Medical Center, Children's Hospital Boston, and their respective satellites under the umbrella of Harvard Medical School. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Mallinckrodt General Clinical Research Center」の詳細全文を読む スポンサード リンク
|